1. Home
  2. AVPT vs IMCR Comparison

AVPT vs IMCR Comparison

Compare AVPT & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AvePoint Inc.

AVPT

AvePoint Inc.

HOLD

Current Price

$13.44

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$34.18

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVPT
IMCR
Founded
2001
2008
Country
United States
United Kingdom
Employees
3443
524
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
AVPT
IMCR
Price
$13.44
$34.18
Analyst Decision
Buy
Buy
Analyst Count
12
10
Target Price
$16.64
$66.33
AVG Volume (30 Days)
2.1M
456.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.39
EPS
N/A
0.23
Revenue
N/A
$249,428,000.00
Revenue This Year
$25.00
$14.57
Revenue Next Year
$19.63
$8.21
P/E Ratio
$1,348.94
$148.70
Revenue Growth
N/A
43.05
52 Week Low
$8.84
$27.56
52 Week High
$16.77
$40.71

Technical Indicators

Market Signals
Indicator
AVPT
IMCR
Relative Strength Index (RSI) 60.35 54.55
Support Level $11.88 $30.48
Resistance Level $13.92 $35.73
Average True Range (ATR) 0.50 1.24
MACD -0.01 -0.09
Stochastic Oscillator 74.82 66.77

Price Performance

Historical Comparison
AVPT
IMCR

About AVPT AvePoint Inc.

AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: